BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qi SX, Sun H, Liu H, Yu J, Jiang ZY, Yan P. Role and mechanism of circ-PRKCI in hepatocellular carcinoma. World J Gastroenterol 2019; 25(16): 1964-1974 [PMID: 31086464 DOI: 10.3748/wjg.v25.i16.1964] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Ma Y, Zhang D, Wu H, Li P, Zhao W, Yang X, Xing X, Li S, Li J. Circular RNA PRKCI silencing represses esophageal cancer progression and elevates cell radiosensitivity through regulating the miR-186-5p/PARP9 axis. Life Sci 2020;259:118168. [PMID: 32739469 DOI: 10.1016/j.lfs.2020.118168] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Sun Y, Sun X, Huang Q. Circ_0000105 promotes liver cancer by regulating miR‐498/PIK3R1. J Gene Med 2020;22. [DOI: 10.1002/jgm.3256] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Han TS, Hur K, Cho HS, Ban HS. Epigenetic Associations between lncRNA/circRNA and miRNA in Hepatocellular Carcinoma. Cancers (Basel) 2020;12:E2622. [PMID: 32937886 DOI: 10.3390/cancers12092622] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
4 Shi X, Ma W, Li Y, Wang H, Pan S, Pan Y, Xu C, Li L. CircPRKCI relieves lipopolysaccharide-induced HK2 cell injury by upregulating the expression of miR-545 target gene ZEB2. Biofactors 2020;46:475-86. [PMID: 32104945 DOI: 10.1002/biof.1620] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
5 Zhang Y, Chen Y, Wan Y, Zhao Y, Wen Q, Tang X, Shen J, Wu X, Li M, Li X, Li J, Li W, Xiao Z, Du F. Circular RNAs in the Regulation of Oxidative Stress. Front Pharmacol 2021;12:697903. [PMID: 34385919 DOI: 10.3389/fphar.2021.697903] [Reference Citation Analysis]
6 Zhang X, Yang H, Zhao L, Li G, Duan Y. Circular RNA PRKCI promotes glioma cell progression by inhibiting microRNA-545. Cell Death Dis 2019;10:616. [PMID: 31409777 DOI: 10.1038/s41419-019-1863-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
7 Qiu L, Xu H, Ji M, Shang D, Lu Z, Wu Y, Tu Z, Liu H. Circular RNAs in hepatocellular carcinoma: Biomarkers, functions and mechanisms. Life Sci 2019;231:116660. [PMID: 31319086 DOI: 10.1016/j.lfs.2019.116660] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
8 Wang X, Li H, Lu Y, Cheng L. Circular RNAs in Human Cancer. Front Oncol 2020;10:577118. [PMID: 33537235 DOI: 10.3389/fonc.2020.577118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Teng F, Zhang JX, Chang QM, Wu XB, Tang WG, Wang JF, Feng JF, Zhang ZP, Hu ZQ. LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma. J Exp Clin Cancer Res 2020;39:235. [PMID: 33168027 DOI: 10.1186/s13046-020-01739-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
10 Zhao X, Wang Y, Yu Q, Yu P, Zheng Q, Yang X, Gao D. Circular RNAs in gastrointestinal cancer: Current knowledge, biomarkers and targeted therapy (Review). Int J Mol Med 2020;46:1611-32. [PMID: 33000182 DOI: 10.3892/ijmm.2020.4731] [Reference Citation Analysis]
11 Zhou H, Chen Y. CircRNA has_circ_0001806 promotes hepatocellular carcinoma progression via the miR-193a-5p/MMP16 pathway. Braz J Med Biol Res 2021;54:e11459. [PMID: 34730679 DOI: 10.1590/1414-431X2021e11459] [Reference Citation Analysis]
12 Li L, Xiao C, He K, Xiang G. Circ_0072088 promotes progression of hepatocellular carcinoma by activating JAK2/STAT3 signaling pathway via miR-375. IUBMB Life 2021;73:1153-65. [PMID: 34148288 DOI: 10.1002/iub.2520] [Reference Citation Analysis]
13 Fu LY, Wang SW, Hu MY, Jiang ZL, Shen LL, Zhou YP, Guo JM, Hu YR. Circular RNAs in liver diseases: Mechanisms and therapeutic targets. Life Sci 2021;264:118707. [PMID: 33144187 DOI: 10.1016/j.lfs.2020.118707] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Wei B, Yu L. Circular RNA PRKCI and microRNA-545 relate to sepsis risk, disease severity and 28-day mortality. Scand J Clin Lab Invest 2020;80:659-66. [PMID: 32985287 DOI: 10.1080/00365513.2020.1827291] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Chen W, Li Y, Zhong J, Wen G. circ-PRKCI targets miR-1294 and miR-186-5p by downregulating FOXK1 expression to suppress glycolysis in hepatocellular carcinoma. Mol Med Rep 2021;23:464. [PMID: 33880589 DOI: 10.3892/mmr.2021.12103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]